Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open‐Label, Randomized, Single‐dose, Crossover Study With Healthy Chinese Volunteers

MLA

Wang, Shumin, et al. “Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open‐Label, Randomized, Single‐dose, Crossover Study With Healthy Chinese Volunteers.” Clinical Pharmacology in Drug Development, vol. 11, no. 8, Aug. 2022, pp. 949–56. EBSCOhost, https://doi.org/10.1002/cpdd.1102.

APA

Wang, S., Wu, F., Han, Y., Ni, S., Guo, S., Dai, Y., Xia, Q., Chang, D., Zhang, J., Wei, H., & Zhao, X. (2022). Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open‐Label, Randomized, Single‐dose, Crossover Study With Healthy Chinese Volunteers. Clinical Pharmacology in Drug Development, 11(8), 949–956. https://doi.org/10.1002/cpdd.1102

Chicago

Wang, Shumin, Feng Wu, Ying Han, Siyang Ni, Shaojie Guo, Yuyang Dai, Qiang Xia, et al. 2022. “Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open‐Label, Randomized, Single‐dose, Crossover Study With Healthy Chinese Volunteers.” Clinical Pharmacology in Drug Development 11 (8): 949–56. doi:10.1002/cpdd.1102.